Bundle of His Introduction (What it is)
The Bundle of His is a short tract of specialized cardiac conduction tissue that carries electrical impulses from the atrioventricular (AV) node to the ventricles.
It is part of cardiac anatomy and physiology, specifically the cardiac conduction system.
Clinically, it is discussed in arrhythmias, atrioventricular block, bundle branch block, and pacing strategies.
It is commonly referenced when interpreting the electrocardiogram (ECG) and during electrophysiology (EP) procedures.
Clinical role and significance
The Bundle of His is the only normal electrical connection between atrial myocardium and ventricular myocardium. After the sinoatrial (SA) node initiates an impulse and the atria depolarize, the AV node provides physiologic delay; the impulse then enters the Bundle of His to rapidly conduct toward the interventricular septum.
From the Bundle of His, conduction proceeds into the right bundle branch and left bundle branch, then through the Purkinje fiber network to activate ventricular myocardium in a coordinated sequence. This coordinated activation supports efficient systolic function and synchrony, which is reflected on the ECG as a narrow QRS complex in normal conduction.
Because it is positioned at a critical junction in the conduction system, disease involving the Bundle of His (or tissue below it) can lead to clinically important bradyarrhythmias such as high-grade AV block, wide-complex conduction patterns such as left bundle branch block (LBBB) or right bundle branch block (RBBB), and symptoms including syncope or presyncope. The Bundle of His is also central to invasive diagnosis during EP studies (e.g., measurement of conduction intervals) and to device therapy concepts such as His bundle pacing, which aims to engage the native conduction system when pacing is required.
Indications / use cases
Common clinical contexts where the Bundle of His is discussed, assessed, or targeted include:
- Evaluation of suspected AV block (first-degree, second-degree, or third-degree/complete heart block)
- Assessment of intraventricular conduction delay, including RBBB, LBBB, or nonspecific intraventricular conduction delay on ECG
- Work-up of unexplained syncope, especially when bradycardia or conduction disease is suspected
- Electrophysiology study to localize the level of conduction delay (AV nodal vs infra-Hisian) using intracardiac recordings
- Planning pacemaker therapy where conduction system pacing (e.g., His bundle pacing) may be considered
- Assessment of new conduction disturbances after cardiac procedures that can affect septal conduction (e.g., valve interventions; the specific risk and approach vary by clinician and case)
- Catheter ablation planning when lesions near the AV node/His region may carry a risk of iatrogenic AV block
- Congenital heart disease or post-surgical anatomy where conduction pathways may be altered and localization is clinically relevant
Contraindications / limitations
The Bundle of His itself is an anatomic structure, so “contraindications” do not apply in the same way they would for a medication or procedure. The closest relevant limitations involve how well clinicians can evaluate or therapeutically engage the His region.
Key limitations and situations where alternative approaches may be preferred include:
- Surface ECG cannot directly visualize His bundle activity; interpretation is indirect (e.g., PR interval and QRS morphology), and localization may remain uncertain
- EP study provides detailed localization but is invasive and may not be necessary in every patient; selection varies by clinician and case
- His bundle pacing can be technically challenging due to small target area, anatomic variability, and the need for stable lead fixation
- In advanced infra-Hisian disease (distal conduction system disease), capturing the His region may not fully correct distal delay; alternative pacing sites may be considered
- Higher pacing thresholds or threshold variability can occur with His region pacing in some patients, which can affect battery longevity and programming strategy (varies by device, material, and institution)
- Infection risk, venous access limitations, and bleeding risk affect any transvenous device procedure; appropriateness depends on the broader clinical scenario
How it works (Mechanism / physiology)
Physiologic principle
Electrical activation normally begins in the SA node, spreads through atrial myocardium, and reaches the AV node. The AV node introduces a delay that allows ventricular filling. The impulse then enters the Bundle of His, which rapidly conducts to the bundle branches and Purkinje system, producing coordinated ventricular depolarization.
Relevant anatomy and structures
- SA node: primary pacemaker initiating atrial depolarization
- AV node: slows conduction; protects ventricles from excessively rapid atrial rates
- Bundle of His: penetrates the fibrous skeleton and carries impulses from atria/AV node into the ventricular conduction system
- Right and left bundle branches: conduct down the interventricular septum
- Purkinje fibers: distribute conduction throughout ventricular myocardium
- Myocardium: working muscle tissue that contracts after depolarization
- Fibrous skeleton: electrically insulates atria from ventricles, making the His bundle the key physiologic bridge
Blood supply to the AV node and proximal conduction system often involves branches from the right coronary artery or left circumflex (depending on coronary dominance), while septal perforators from the left anterior descending artery commonly contribute to septal conduction tissue supply. Individual patterns vary.
Onset, duration, and reversibility
Onset and duration concepts do not apply to the Bundle of His as a structure. Clinically, what varies is conduction through the His-Purkinje system: it can be normal, intermittently impaired (e.g., rate-dependent block), or persistently impaired due to fibrosis, ischemia, infiltrative disease, or procedural injury. Some conduction abnormalities are transient, while others are progressive; reversibility varies by cause.
Bundle of His Procedure or application overview
The Bundle of His is not a single procedure, but it is commonly assessed (noninvasively and invasively) and may be targeted during pacing. A general workflow depends on the clinical question.
Evaluation / exam
- History focused on symptoms of bradycardia or conduction disease (e.g., syncope, dizziness, exertional intolerance, palpitations)
- Review of medication exposures that can slow AV conduction (e.g., beta blockers, non-dihydropyridine calcium channel blockers, digoxin) as part of standard clinical assessment
- Physical exam emphasizing heart rate, perfusion, and signs of heart failure
Diagnostics
- 12-lead ECG to assess PR interval, QRS duration, axis, and bundle branch patterns
- Telemetry or ambulatory monitoring (Holter/event monitor) for intermittent block or pauses
- Echocardiography to evaluate structural heart disease and ventricular function when relevant
- Laboratory evaluation may be used to assess contributing factors such as electrolyte abnormalities or thyroid dysfunction, depending on context
Preparation (if an invasive study or device therapy is pursued)
- Pre-procedural planning for venous access, anticoagulation strategy, and infection prevention measures, tailored to the individual case
- Review of prior ECGs and imaging to understand baseline conduction and anatomy
Intervention / testing (selected examples)
- Electrophysiology (EP) study: intracardiac catheters record conduction signals; clinicians may measure intervals such as the AH interval (atrium-to-His) and HV interval (His-to-ventricle) to help localize conduction delay (AV nodal vs infra-Hisian)
- His bundle pacing (a form of conduction system pacing): mapping is used to identify a His potential; a pacing lead is positioned and tested for capture, with attention to QRS morphology and pacing thresholds
Immediate checks
- Confirmation of rhythm stability and conduction pattern on ECG
- If a device is implanted: device interrogation for sensing, capture threshold, impedance, and initial programming parameters
Follow-up / monitoring
- Ongoing ECG review and symptom assessment
- If pacing is used: periodic device interrogation and programming adjustments as needed; schedule and approach vary by institution and patient factors
Types / variations
Important variations related to the Bundle of His include anatomic, physiologic, and clinical categories:
- Anatomic segments: the His bundle is often described as having a penetrating portion (through the fibrous skeleton) and a branching portion (transition to bundle branches), with variability in course and proximity to nearby structures
- Level of conduction block
- Supra-Hisian (above the His bundle, typically AV nodal)
- Intra-Hisian (within the His bundle)
- Infra-Hisian (below the His bundle, within bundle branches/Purkinje system)
- Conduction disturbance pattern
- Intermittent vs persistent block (e.g., paroxysmal high-grade AV block vs chronic complete heart block)
- Rate-dependent aberrancy (e.g., bundle branch block appearing at higher rates)
- Pacing-related variations
- Selective His bundle capture: pacing activates the His bundle without direct myocardial capture, often producing a QRS similar to intrinsic conduction
- Nonselective His bundle capture: pacing captures both His tissue and adjacent myocardium, often with a fused QRS appearance
- Alternative conduction system pacing site: left bundle branch area pacing is often discussed alongside His bundle pacing; exact definitions and techniques vary by clinician and device system
Advantages and limitations
Advantages:
- Supports a clear conceptual framework for interpreting AV conduction on ECG (PR interval, QRS width, and bundle branch patterns)
- Helps localize conduction disease when combined with EP testing (e.g., AV nodal vs infra-Hisian delay)
- Provides a physiologic target for conduction system pacing in selected patients requiring pacing
- Explains key clinical patterns such as wide QRS due to bundle branch block and the relationship to ventricular dyssynchrony
- Useful in procedural risk assessment when interventions are performed near the septum and AV conduction tissue (risk varies by procedure and patient)
Limitations:
- Surface ECG findings are indirect and cannot measure His conduction signals directly
- EP testing and His-region pacing require specialized expertise, equipment, and an invasive approach
- Anatomic variability can make localization and stable lead placement challenging in some patients
- Distal conduction disease may limit the ability of His-targeted pacing to normalize ventricular activation
- Pacing thresholds and long-term lead performance can vary, influencing programming and device longevity (varies by device, material, and institution)
- Conduction abnormalities often reflect broader myocardial disease (ischemic cardiomyopathy, infiltrative disease, fibrosis), so addressing the His region does not address all underlying pathology
Follow-up, monitoring, and outcomes
Monitoring and outcomes related to the Bundle of His depend mainly on the cause and level of conduction disease, the presence of structural heart disease, and whether a device therapy is used.
Key factors that commonly influence follow-up considerations include:
- Severity and location of conduction impairment: infra-Hisian disease is often associated with wider QRS complexes and may carry different clinical implications than isolated AV nodal delay; evaluation is individualized
- Comorbidities: coronary artery disease, cardiomyopathy, valvular disease, chronic kidney disease, and infiltrative processes can influence conduction stability and overall prognosis
- Medication effects and metabolic factors: AV nodal–blocking drugs and electrolyte disturbances can contribute to bradyarrhythmias or worsen existing conduction delay
- Hemodynamics and ventricular function: reduced left ventricular ejection fraction and symptoms of heart failure may affect whether pacing strategies aimed at resynchrony (e.g., cardiac resynchronization therapy, CRT) are considered
- Device-related monitoring (if pacing is used): capture thresholds, sensing, lead impedance, pacing percentage, battery status, and stored arrhythmia episodes are typically reviewed at intervals that vary by institution and patient risk
- Rehabilitation and functional status: recovery trajectory and symptom improvement depend on baseline conditioning and concurrent cardiac disease; participation and response vary by clinician and case
Outcomes are typically assessed by symptom burden (e.g., syncope prevention), rhythm stability, ECG/QRS characteristics, and (when relevant) ventricular function trends on imaging. Because patient populations and device approaches differ, expected outcomes vary by clinician and case.
Alternatives / comparisons
How the Bundle of His is approached clinically depends on whether the goal is diagnosis (localizing conduction disease) or therapy (pacing strategy).
Diagnostic comparisons:
- Observation and serial ECGs: appropriate when conduction findings are stable and symptoms are absent or unclear; clinical thresholds for escalation vary
- Ambulatory monitoring (Holter/event monitor): useful for intermittent symptoms or suspected paroxysmal AV block; captures real-world rhythm behavior
- Implantable loop recorder: considered when episodes are infrequent but concerning; selection varies by clinician and case
- Electrophysiology study: provides direct intracardiac assessment (e.g., His potentials and HV interval) but is invasive and typically reserved for selected scenarios
Therapeutic comparisons (when pacing is needed):
- Right ventricular (RV) pacing: widely used and technically straightforward, but chronic RV apical pacing can produce ventricular dyssynchrony in some patients; relevance depends on pacing burden and baseline ventricular function
- His bundle pacing (conduction system pacing): aims to use the native His-Purkinje system and may preserve a more physiologic activation pattern in selected cases; feasibility and performance vary
- Left bundle branch area pacing: another conduction system pacing approach that targets the left-sided conduction system region; may be considered when His capture is difficult or thresholds are high, depending on operator preference
- Cardiac resynchronization therapy (CRT): uses biventricular pacing to improve synchrony in selected patients (often with reduced ejection fraction and wide QRS, such as LBBB); candidacy depends on guideline-based criteria and clinical context
- Medical therapy: may address contributing causes (e.g., ischemia management, medication adjustments) but does not replace pacing when clinically significant bradycardia persists; decisions are individualized
Bundle of His Common questions (FAQ)
Q: Where exactly is the Bundle of His located?
It is located at the base of the heart near the interventricular septum, emerging from the AV node and passing through the fibrous skeleton. It then divides into the right and left bundle branches. Exact anatomic course can vary between individuals.
Q: Can the Bundle of His be seen on a standard ECG?
Not directly. A 12-lead ECG reflects the downstream effects of conduction (PR interval, QRS width, bundle branch patterns), but it does not record the His bundle signal itself. Direct recording of a His potential typically requires an EP study.
Q: What conditions commonly involve the Bundle of His?
AV block can occur above, within, or below the His bundle, and bundle branch blocks reflect disease in the conduction system beyond the His bundle. Ischemia, fibrosis/degeneration, infiltrative disease, and procedural injury can all affect conduction. The specific cause is determined by the broader clinical evaluation.
Q: Is His bundle pacing the same as a regular pacemaker?
His bundle pacing is a type of pacing approach that aims to stimulate the conduction system at or near the His bundle rather than pacing only the right ventricular myocardium. It is delivered by a pacemaker system, but lead placement targets differ. Suitability varies by clinician and case.
Q: Does evaluation or treatment involving the His region cause pain, and is anesthesia used?
Noninvasive assessment (ECG, ambulatory monitoring) is generally not painful. Invasive procedures such as EP studies or pacemaker implantation typically use local anesthesia with sedation strategies that vary by institution and patient factors. Discomfort expectations depend on the procedure and individual tolerance.
Q: How long do the results “last” if a pacing strategy targets the His bundle?
The goal of pacing is ongoing rhythm support, so its effect persists while the device and lead function appropriately. Over time, thresholds and lead performance can change and may require reprogramming or revision in selected cases. Longevity varies by device, material, and institution.
Q: How safe are procedures that involve the Bundle of His (EP study, pacing, ablation near the area)?
These procedures are commonly performed in specialized settings, but they carry risks such as bleeding, infection, vascular injury, and arrhythmia, with risk magnitude depending on patient factors and the specific intervention. Procedures near the AV node/His region can carry a risk of AV block, which is part of procedural planning and consent. Overall risk assessment is individualized.
Q: What is the typical cost range for evaluation or pacing related to the Bundle of His?
Costs vary widely by country, health system, insurance coverage, facility type, and whether hospitalization or device implantation is involved. EP studies and implanted devices generally cost more than outpatient ECG monitoring. Exact estimates require institution-specific billing information.
Q: Are there activity restrictions after a procedure related to His bundle pacing?
Activity guidance depends on the type of procedure and institutional protocol. After device implantation, short-term arm and wound-care precautions are commonly discussed to protect the lead and pocket during early healing, but specifics vary by clinician and case. Longer-term activity recommendations are individualized based on underlying heart disease and device function.
Q: How often is follow-up needed if the conduction system is affected or a device is implanted?
Follow-up frequency depends on symptom burden, the stability of conduction findings, and whether a pacemaker/CRT device is present. Device patients typically undergo periodic interrogations, with intervals adjusted based on battery status, thresholds, and clinical status. Monitoring schedules vary by institution and patient risk profile.